Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (411-420 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|January 1, 1988
Systemic arterial hypertension and coronary atherosclerosis. Observations in survivors of a first myocardial infarctionG Sánchez Torres, C Posadas Romero, C Tena Tamayo, et al.
Drugs|January 1, 1988
Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoringB Trimarco, G Rosiello, P Feldhaus, et al.
Drugs|May 7, 2021
Melphalan Flufenamide (Melflufen): First ApprovalSohita Dhillon
Drugs|May 27, 2020
The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19Nadia Panera, Alberto Eugenio Tozzi, Anna Alisi
Drugs|May 27, 2020
Functional Constipation: Individualising Assessment and TreatmentJasper Pannemans, Imke Masuy, Jan Tack
Drugs|June 7, 2020
Selumetinib: First ApprovalAnthony Markham, Susan J Keam
Drugs|April 24, 2020
Pharmacokinetics and Pharmacodynamics of PosaconazoleLu Chen, Elke H J Krekels, Paul E Verweij, et al.
Drugs|September 16, 2021
Furmonertinib: First ApprovalEmma D Deeks
Drugs|September 15, 2021
Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative ReviewLaura P B Elbers, Hennie G Raterman, Willem F Lems
Drugs|January 1, 1988
The relevance of serotonin antagonism in the treatment of hypertensionA E Doyle
Pageof 708

Showing results (411-420 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|January 1, 1988
Systemic arterial hypertension and coronary atherosclerosis. Observations in survivors of a first myocardial infarctionG Sánchez Torres, C Posadas Romero, C Tena Tamayo, et al.
Drugs|January 1, 1988
Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoringB Trimarco, G Rosiello, P Feldhaus, et al.
Drugs|May 7, 2021
Melphalan Flufenamide (Melflufen): First ApprovalSohita Dhillon
Drugs|May 27, 2020
The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19Nadia Panera, Alberto Eugenio Tozzi, Anna Alisi
Drugs|May 27, 2020
Functional Constipation: Individualising Assessment and TreatmentJasper Pannemans, Imke Masuy, Jan Tack
Drugs|June 7, 2020
Selumetinib: First ApprovalAnthony Markham, Susan J Keam
Drugs|April 24, 2020
Pharmacokinetics and Pharmacodynamics of PosaconazoleLu Chen, Elke H J Krekels, Paul E Verweij, et al.
Drugs|September 16, 2021
Furmonertinib: First ApprovalEmma D Deeks
Drugs|September 15, 2021
Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative ReviewLaura P B Elbers, Hennie G Raterman, Willem F Lems
Drugs|January 1, 1988
The relevance of serotonin antagonism in the treatment of hypertensionA E Doyle
Pageof 708